[go: up one dir, main page]

FI903106A0 - Preventivsystem och -foerfarande. - Google Patents

Preventivsystem och -foerfarande.

Info

Publication number
FI903106A0
FI903106A0 FI903106A FI903106A FI903106A0 FI 903106 A0 FI903106 A0 FI 903106A0 FI 903106 A FI903106 A FI 903106A FI 903106 A FI903106 A FI 903106A FI 903106 A0 FI903106 A0 FI 903106A0
Authority
FI
Finland
Prior art keywords
day
progestin
stage
composition
follow
Prior art date
Application number
FI903106A
Other languages
English (en)
Other versions
FI103951B (fi
FI103951B1 (fi
Inventor
Samuel A Pasquale
Original Assignee
Samuel A Pasquale
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22989203&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI903106(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Samuel A Pasquale filed Critical Samuel A Pasquale
Publication of FI903106A0 publication Critical patent/FI903106A0/fi
Application granted granted Critical
Publication of FI103951B publication Critical patent/FI103951B/fi
Publication of FI103951B1 publication Critical patent/FI103951B1/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Communication Control (AREA)
  • Control Of Steam Boilers And Waste-Gas Boilers (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Transplanting Machines (AREA)
  • Moving Of Heads (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
FI903106A 1988-10-20 1990-06-20 Ehkäisyjärjestelmä FI103951B1 (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US07/260,447 US4921843A (en) 1988-10-20 1988-10-20 Contraception system and method
US26044788 1988-10-20
PCT/US1989/004697 WO1990004330A1 (en) 1988-10-20 1989-10-19 Contraception system and method
US8904697 1989-10-19

Publications (3)

Publication Number Publication Date
FI903106A0 true FI903106A0 (fi) 1990-06-20
FI103951B FI103951B (fi) 1999-10-29
FI103951B1 FI103951B1 (fi) 1999-10-29

Family

ID=22989203

Family Applications (1)

Application Number Title Priority Date Filing Date
FI903106A FI103951B1 (fi) 1988-10-20 1990-06-20 Ehkäisyjärjestelmä

Country Status (15)

Country Link
US (1) US4921843A (fi)
EP (1) EP0397823B1 (fi)
JP (1) JP3001216B2 (fi)
KR (1) KR0182283B1 (fi)
AT (1) ATE175353T1 (fi)
AU (1) AU620940B2 (fi)
CA (1) CA2001144C (fi)
DE (1) DE68928897T2 (fi)
FI (1) FI103951B1 (fi)
HU (2) HUT51899A (fi)
IL (1) IL92069A0 (fi)
NZ (1) NZ231091A (fi)
PT (1) PT92069B (fi)
WO (1) WO1990004330A1 (fi)
ZA (1) ZA897977B (fi)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5108995A (en) * 1987-09-24 1992-04-28 Jencap Research Ltd. Hormone preparation and method
DE4104385C1 (fi) * 1991-02-09 1992-08-13 Marika Dr.Med. 6509 Framersheim De Ehrlich
US6407082B1 (en) * 1996-09-13 2002-06-18 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a vitamin D compound
DE4344405C2 (de) * 1993-12-24 1995-12-07 Marika Dr Med Ehrlich Ovulationshemmendes Mittel und Verfahren zur hormonalen Kontrazeption
DE4411585A1 (de) * 1994-03-30 1995-10-05 Schering Ag Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption
DE4429374C1 (de) 1994-08-12 1996-02-01 Jenapharm Gmbh Pharmazeutische Präparate zur Kontrazeption/Hormonsubstitution mit biogener Estrogenkomponente
DE19513662A1 (de) * 1995-04-08 1996-10-10 Schering Ag Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption
US20050032756A1 (en) * 1995-10-28 2005-02-10 Michael Dittgen Multistage preparation for contraception based on natural estrogens
DE19540253C2 (de) * 1995-10-28 1998-06-04 Jenapharm Gmbh Mehrphasenpräparat zur Kontrazeption auf der Basis natürlicher Estrogene
US5747480A (en) * 1996-05-08 1998-05-05 American Home Products Corporation Oral contraceptive
US5858405A (en) * 1996-07-26 1999-01-12 American Home Products Corporation Oral contraceptive
US6451778B1 (en) 1996-07-26 2002-09-17 Wyeth Oral contraceptive
AU3888697A (en) * 1996-07-26 1998-02-20 American Home Products Corporation Progestin/estrogen oral contraceptive
US5888543A (en) * 1996-07-26 1999-03-30 American Home Products Corporation Oral contraceptives
US6479475B1 (en) 1996-07-26 2002-11-12 Wyeth Oral contraceptive
US6028064A (en) 1996-09-13 2000-02-22 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of progestin products
US6765002B2 (en) 2000-03-21 2004-07-20 Gustavo Rodriguez Prevention of ovarian cancer by administration of products that induce transforming growth factor-β and/or apoptosis in the ovarian epithelium
US6034074A (en) 1996-09-13 2000-03-07 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a Vitamin D compound
US6511970B1 (en) 1996-09-13 2003-01-28 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium
WO2001030355A1 (fr) 1999-10-25 2001-05-03 Laboratoire Theramex Medicament contraceptif a base d'un progestatif et d'un estrogene et son mode de preparation
FR2754179B1 (fr) 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
US6251956B1 (en) 1998-08-20 2001-06-26 Ortho Pharmaceutical Corporation Combination progestin oral contraceptive regimen
ATE279198T1 (de) * 1997-08-27 2004-10-15 Ortho Mcneil Pharm Inc Kombinationen von endometrium schonenden gestagenen und endometrium atrophisierenden gestagenen mit estrogenen, bei der oralen empfängnisverhütung
WO2000028995A1 (en) * 1998-11-12 2000-05-25 Warner Chilcott Laboratories Ireland Limited Graduated progestin contraceptive
US6214815B1 (en) 1998-12-23 2001-04-10 Ortho-Mcneil Pharmaceuticals, Inc. Triphasic oral contraceptive
DE60040214D1 (de) * 1999-02-26 2008-10-23 Shionogi & Co Kaubare weichkapseln mit verbesserten verabreichungseigenschaften sowie verfahren zu deren herstellung
US6660726B2 (en) 2000-03-10 2003-12-09 Endeavor Pharmaceuticals Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same
US7989436B2 (en) 2003-07-23 2011-08-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and pharmaceutical formulations comprising the same
US7459445B2 (en) * 2000-03-10 2008-12-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and topical pharmaceutical formulations of the same
US6855703B1 (en) 2000-03-10 2005-02-15 Endeavor Pharmaceuticals Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds
US20050113351A1 (en) * 2000-03-21 2005-05-26 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US20010044431A1 (en) * 2000-03-21 2001-11-22 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US20040176336A1 (en) * 2000-03-21 2004-09-09 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
EP1293210B1 (en) * 2001-05-23 2003-11-19 Pantarhei Bioscience B.V. Means and method for hormonal contraception
CN100581550C (zh) * 2001-12-05 2010-01-20 杜拉美德药物有限公司 预防怀孕和减少经期前症状的口服避孕药
JP2004140323A (ja) * 2002-08-20 2004-05-13 Sharp Corp 半導体レーザ装置およびその製造方法
US6992075B2 (en) * 2003-04-04 2006-01-31 Barr Laboratories, Inc. C(14) estrogenic compounds
WO2004091535A2 (en) * 2003-04-11 2004-10-28 Barr Laboratories, Inc. Methods of administering estrogens and progestins
JP2007511533A (ja) * 2003-11-14 2007-05-10 ワーナー・チルコット・カンパニー・インコーポレーテッド 段階的エストロゲン避妊薬
EP1550447A1 (en) * 2004-01-02 2005-07-06 Schering Aktiengesellschaft Menstrual cycle control and improvement of conception rates in females
CA2556459C (en) * 2004-03-19 2013-01-15 Warner Chilcott Company, Inc. Extended cycle multiphasic oral contraceptive method
DE102004019743B4 (de) * 2004-04-20 2008-11-27 Bayer Schering Pharma Aktiengesellschaft Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens
WO2006084082A1 (en) * 2005-02-03 2006-08-10 Duramed Pharmaceuticals, Inc. Compositions of unconjugated estrogens and methods for their use
US7704984B2 (en) * 2005-04-22 2010-04-27 Warner Chilcott Company, Llc Extended estrogen dosing contraceptive regimen
US8153616B2 (en) * 2005-10-17 2012-04-10 Bayer Pharma Aktiengesellschaft Combination preparation for oral contraception and oral therapy of dysfunctional uterine bleeding containing estradiol valerate and dienogest and method of using same
EP1930010A1 (de) * 2006-10-20 2008-06-11 Bayer Schering Pharma Aktiengesellschaft Verwendung von Estradiolvalerat oder 17ß-Estradiol in Kombination mit Dienogest zur oralen Therapie für den Erhalt und/oder die Steigerung der weiblichen Libido

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6615481A (fi) * 1966-11-02 1968-05-03
US3409721A (en) 1967-09-15 1968-11-05 Neomed Lab Inc Oral dosage system effective to control the reproduction cycle
US4372951A (en) * 1979-10-11 1983-02-08 Nichols Vorys Vaginal delivery for physiologic follicular-luteal steroid treatment
US4616006A (en) * 1983-09-26 1986-10-07 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
US4544554A (en) * 1983-09-26 1985-10-01 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
US4628051A (en) * 1983-09-26 1986-12-09 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
DE3347125A1 (de) * 1983-12-22 1985-07-11 Schering AG, 1000 Berlin und 4709 Bergkamen Mehrstufenkombinationspraeparat und seine verwendung zur oralen kontrazeption

Also Published As

Publication number Publication date
KR0182283B1 (ko) 1999-05-01
KR900701277A (ko) 1990-12-01
PT92069B (pt) 1995-06-30
HUT51899A (en) 1990-06-28
FI103951B (fi) 1999-10-29
EP0397823A1 (en) 1990-11-22
CA2001144C (en) 1999-07-20
JP3001216B2 (ja) 2000-01-24
HU211931A9 (en) 1996-01-29
EP0397823B1 (en) 1999-01-07
FI103951B1 (fi) 1999-10-29
NZ231091A (en) 1995-12-21
US4921843A (en) 1990-05-01
ATE175353T1 (de) 1999-01-15
AU620940B2 (en) 1992-02-27
PT92069A (pt) 1990-04-30
WO1990004330A1 (en) 1990-05-03
DE68928897D1 (de) 1999-02-18
DE68928897T2 (de) 1999-07-29
EP0397823A4 (en) 1991-04-03
ZA897977B (en) 1990-07-25
AU4497089A (en) 1990-05-14
IL92069A0 (en) 1990-07-12
JPH03502932A (ja) 1991-07-04
CA2001144A1 (en) 1990-04-20

Similar Documents

Publication Publication Date Title
FI903106A0 (fi) Preventivsystem och -foerfarande.
NO976067D0 (no) Farmasöytisk kombinasjonspreparat, sett og fremgangsmåte for hormonell prevensjon
ES2033850T3 (es) Forma farmaceutica consistente en una combinacion dosificada, destinada al tratamiento de las mujeres pre-menopausicas.
BR9709934A (pt) Kit de terapia de reposição hormonal e/ou contraceptivo uso de unidades de dosagem diária consistindo essecialmente de um progestogênio e processo de preparação de um sistema de liberação de droga
ATE216241T1 (de) Sehr niedrigdosiertes orales kontrazeptiv mit weniger menstruationsblutungen und verzögerter wirkung
CA2188907A1 (en) Combination compound for contraception based on natural estrogen
KR960706344A (ko) 호르몬 피임 및/또는 여드름 치료 수단 및 방법(means and method for hormonal contraception and/or the treatment of acne)
KR890700349A (ko) 피임 및 유방암 억제용 조성물 및 이의 제조방법
KR920011514A (ko) 프로게스토겐만을 함유하는 피임제
FI971742A7 (fi) Kompetitiivisia progesteroniantagonisteja tarpeen sanelemaan raskauden ehkäisyyn naisilla
SE9403389D0 (sv) Pharmaceutical composition containing derivattves of sex hormones
CA2361081A1 (en) Chaperonin 10 and .beta.-interferon therapy of multiple sclerosis
NZ504351A (en) Contraceptive kit comprising progestogen and anti-progestogen and use in treating bleeding induced by a progestogen-only contraceptive regimen
RU94040720A (ru) Экстроген (прогестин) антипрогестиновый, способ пероральной контрацепции и регулирования менструаций, фармацевтическая композиция и набор лекарственных средств
TW324663B (en) Interferon-ω(IFN-ω) as anti-HIV (human immune deficiency virus) agent

Legal Events

Date Code Title Description
FG Patent granted

Owner name: SAVIENT PHARMACEUTICALS, INC.